Global Heart Failure Drugs Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025

Report ID: BMRC 2447 | Number of pages: 193 | Publish Date: Jan 2020 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New

Heart Failure Drugs Market Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

The global heart failure drugs market is generic in nature; as many generic drug manufacturers and pharmaceutical giants are providing drugs for a disease. However; the arrival of innovative drugs such as EOM, is expected to change the market dynamics. AstraZeneca and Novartis hold the major share of the global heart failure drugs market with their drugs Toprol-XL and wog, respectively. The companies also hold a strong pipeline and are expected to remain the market leaders during the forecast period. Based on the drug class the market can be segmented into Beta blockers, ARBs, and ACE inhibitors. Angiotensin II receptor blockers (ARB) are a group of pharmaceuticals that modify the renin-angiotensin system. The heart disease drugs market is experiencing growth in the ARBs segment because it reduces the risk of death caused by heart failure and minimizes the chance of hospitalization of people with heart failure.

The latest trend gaining momentum in the market is investment inclination toward developing countries. Countries such as India, China, and Brazil are turning out to be some of the most attractive countries for pharmaceutical companies across the globe. Many factors such as huge share of global population and rising geriatric population are leading to the high growth of healthcare sector in the developing countries. In addition, the rising cases of lifestyle disorders such as obesity and diabetes also contribute to higher heart failure cases in the region.

One of the major drivers for this market is rising geriatric population. A large number of health problems are associated with the rising age, and CVDs are major among them. As a person gets older, the blood vessels become less flexible, thus making it difficult for the blood to flow through them. Rising age accompanied by other factors such as lifestyle-oriented diseases and smoking increases the risk of CVDs, especially heart failure. Heart failure in the geriatric population will continue to be a rising health burden globally, as this population represents the majority of the heart failure patients. Hence, rising geriatric population drives the demand for heart failure drugs during the forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Heart Failure Drugs. This report studies the global market size of Heart Failure Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Heart Failure Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

    Amgen
    AstraZeneca
    Bayer
    Novartis
    Gilead
    GlaxoSmithKline
    Pfizer
    Teva Pharmaceutical industries

Market Segment by Product Type

    Beta Blockers
    ARBs
    ACE Inhibitors

Market Segment by Application

    Hospital
    Pharmacy
    Others

In this study, the years considered to estimate the market size of Heart Failure Drugs are as follows:

    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

Global Heart Failure Drugs Market 2019 Industry research report is a proficient and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific). It covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key Vendors operating in this Global market. This Report Focuses on the Major Drivers, Restraints, Opportunities and Threats for Key Players. It also Provides Granular Analysis of Market Share, Segmentation, Revenue Forecasts and Regional Analysis till 2025.



The study objectives are:

    To analyze and research the Heart Failure Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Heart Failure Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Interested in this report?
Get your sample now!
Table of Content

Chapter 1 Global Heart Failure Drugs Market: Summary and Quantitative Analysis 
1.1 Report Description 
1.2 Global Heart Failure Drugs Market Revenue Overview 
1.3 Global Heart Failure Drugs Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025 

Chapter 2 Global Heart Failure Drugs Market: Overview and Qualitative Analysis 
2.1 Executive Summary 
2.2 Market Drivers 
2.3 Market Restraints 
2.4 Market Opportunities 
2.5 Market Trends 
2.6 Global Heart Failure Drugs Market: SWOT Analysis 
2.7 Global Heart Failure Drugs Market: PEST Analysis 
2.7 Global Heart Failure Drugs Market: Porter’s Five Forces Analysis 
2.8 Global Heart Failure Drugs Market: Attractiveness Analysis 
2.8.1 Global Heart Failure Drugs Market: Attractiveness Analysis by Type 
2.8.2 Global Heart Failure Drugs Market: Attractiveness Analysis by Grade 
2.8.3 Global Heart Failure Drugs Market: Attractiveness Analysis by Regional 

Chapter 3 Competitive Analysis 
3.1 Global Heart Failure Drugs Market 
3.1.1 Global Heart Failure Drugs market Revenue (USD Billion), By Players 2018 
3.1.2 Global Heart Failure Drugs Market Revenue Share (%), By Players 2018 

Chapter 5 Global Heart Failure Drugs Market: By Product Type 
5.1 Global Heart Failure Drugs Market Share (%), By Product Type, 2018 
5.2 Global Heart Failure Drugs Market Revenue (USD Billion), By Product Type, 2015 – 2025 
5.3 Global Heart Failure Drugs Market Revenue (USD Billion), By Retro,2015-2025 
5.4 Global Heart Failure Drugs Market Revenue (USD Billion), By Standing/Self-Balancing, 2015-2025 
5.4 Global Heart Failure Drugs Market Revenue (USD Billion), By Folding, 2015-2025 
5.5 Global Heart Failure Drugs Market Revenue Share (%), By Product Type, 2015 – 2025 
5.6 Global Heart Failure Drugs Market Revenue Market Share (%), By Product Type, 2015-2025 

Chapter 6 Global Heart Failure Drugs Market: By Product Type 
6.1 Global Heart Failure Drugs Market Share (%), By Product Type, 2018 
6.2 Global Heart Failure Drugs Market Revenue (USD Billion), By Type, 2015 – 2025 

Chapter 7 North America Heart Failure Drugs Market Analysis 
7.1 North America Market Snapshot 
7.1.1 North America Heart Failure Drugs Market Revenue and Growth Rate (%), 2015-2025. 
7.1.2 North America Heart Failure Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
7.1.3 North America Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
7.1.5 North America Heart Failure Drugs  Revenue (USD Billion) Overview, By Product Type, 2015-2025 
7.1.6 North America Heart Failure Drugs  Revenue (USD Billion) Overview, By Product Type , 2015-2025 

Chapter 8 Europe Heart Failure Drugs Market Analysis 
8.1 Europe Market Snapshot 
8.1.1 Europe Heart Failure Drugs Market Revenue and Growth Rate (%), 2015-2025. 
8.1.2 Europe Heart Failure Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
8.1.3 Europe Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
8.1.5 Europe Heart Failure Drugs  Revenue (USD Billion) Overview, By Product Type, 2015-2025 
8.1.6 Europe Heart Failure Drugs  Revenue (USD Billion) Overview, By Type, 2015-2025 

Chapter 9 Asia Pacific Heart Failure Drugs Market Analysis 
9.1 Asia Pacific Market Snapshot 
9.1.1 Asia Pacific Heart Failure Drugs Market Revenue and Growth Rate (%), 2015-2025. 
9.1.2 Asia Pacific Heart Failure Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
9.1.3 Asia Pacific Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
9.1.5 Asia Pacific Heart Failure Drugs  Revenue (USD Billion) Overview, By Product Type, 2015-2025 
9.1.6 Asia Pacific Heart Failure Drugs  Revenue (USD Billion) Overview, By Type, 2015-2025 

Chapter 10 Latin America Heart Failure Drugs Market Analysis 
10.1 Latin America Market Snapshot 
10.1.1 Latin America Heart Failure Drugs Market Revenue and Growth Rate (%), 2015-2025. 
10.1.2 Latin America Heart Failure Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
10.1.3 Latin America Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
10.1.5 Latin America Heart Failure Drugs  Revenue (USD Billion) Overview, By Product Type, 2015-2025 
10.1.6 Latin America Heart Failure Drugs  Revenue (USD Billion) Overview, By Type, 2015-2025 

Chapter 11 Middle East & Africa Heart Failure Drugs Market Analysis 
11.1 Middle East & Africa Market Snapshot 
11.1.1 Middle East & Africa Heart Failure Drugs Market Revenue and Growth Rate (%), 2015-2025. 
11.1.2 Middle East & Africa Heart Failure Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025 
11.1.3 Middle East & Africa Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 

11.1.5 Middle East & Africa Heart Failure Drugs  Revenue (USD Billion) Overview, By Product Type, 2015-2025 
11.1.6 Middle East & Africa Heart Failure Drugs  Revenue (USD Billion) Overview, By Type, 2015-2025 

Chapter 12 Competitive Analysis 
12.1 Company 1.
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
12.1.2 Company 1. Total Company Revenue 2015-2018 
12.1.3 Company 1. Total Company Revenue, By Segment of Business 2015-2018 
12.1.4 Company 1. Total Company Revenue, By Region 2015-2018 
12.1.5 Company 1. Global Heart Failure Drugs Product Category and Description 
12.1.6 Company 1. Recent Activity 2015-2019 
12.1.7 Main Business/Business Overview 
12.1.8 Business Strategy 
12.1.9 SWOT Analysis 
12.2 Company 2. 
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
12.2.2 Company 2. Total Company Revenue 2015-2018 
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018 
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018 
12.2.5 Company 2. Global Heart Failure Drugs Product Category and Description 
12.2.6 Company 2. Recent Activity 2015-2019 
12.2.7 Main Business/Business Overview 
12.2.8 Business Strategy
12.2.9 SWOT Analysis 
12.3 Company 3 
12.3.1 Business Overview 
12.3.2 Company 3Market Product Category and Description & Specification 
12.3.3 Main Business/Business Overview 
12.3.4 Business Strategy 
12.3.5 SWOT Analysis 
12.4 Company 4. 
12.4.1 Business Overview 
12.4.2 Company 4.Company Total Company Revenue 2015-2018
12.4.3 Company 4.Company Total Company Revenue, By Segment of Business 2015-2018 
12.4.4 Company 4.Company Total Company Revenue, By Region of Business 2015-2018 
12.4.5 Company 4.Company Product Category, Specification and Description 
12.4.6 Company 4.Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019 
12.4.7 Company 4.Company Main Business/Business Overview 
12.4.8 Business Strategy 
12.4.9 SWOT Analysis 
12.5 Company 5 
12.5.1 Business Overview 
12.5.2 Company 5 Company Net Sales 2015-2018 
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018 
12.5.4 Company 5 Company Net Sales, By Region 2015-2018 
12.5.5 Company 5  Heart Failure Drugs Market Product Category and Specification 
12.5.6 Company 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 
12.5.7 Company 5 Main Business/Business Overview 
12.5.8 Business Strategy 
12.5.9 SWOT Analysis 
12.6 Company 6 
12.6.1 Business Overview 
12.6.2 Company 6 Heart Failure Drugs Market Product Category and Specification 
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019 
12.6.4 Company 6 Main Business/Business Overview 
12.6.5 Business Strategy 
12.6.6 SWOT Analysis 

Chapter 13 Market Research  Findings & Conclusion 

Chapter 14 Research Methodology 
14.1 Research Process 
14.2 Primary Research 
14.3 Secondary Research 
14.4 Market Size Estimates 
14.5 Forecast Model 
14.7 Who is This Report For? 
14.8 USP’s of Report 
 
List of Figures 

FIG. 1 Global Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025 
FIG. 4 Global Heart Failure Drugs Market: Attractiveness Analysis By Product Type 
FIG. 5 Global Heart Failure Drugs Market: Attractiveness Analysis By Type 
FIG. 6 Global Heart Failure Drugs  Market: Attractiveness Analysis by Regional 
FIG. 7 Global Heart Failure Drugs Market 
FIG. 8 Global Heart Failure Drugs Market Share (%), By Product Type, 2018 
FIG. 9 Global Heart Failure Drugs Market Revenue (USD Billion), By Application, 2015-2025 
FIG. 10 Global Heart Failure Drugs Market Revenue (USD Billion), By End Use , 2015-2025 
FIG. 10 Global Heart Failure Drugs Market Revenue (USD Billion), By Type, 2015-2025
FIG. 11 Global Heart Failure Drugs Market Revenue Market Share (%), By Product Type, 2015-2025 
FIG. 20 North America Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 21 North America Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 22 Europe Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 23 Europe Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 24 Asia Pacific Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 25 Asia Pacific Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 26 Latin America Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 27 Latin America Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 28 Middle East & Africa Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025. 
FIG. 29 Middle East & Africa Heart Failure Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025. 
FIG. 30 Company 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) 
FIG. 31 Company 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 32 Company 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million) 
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 119
FIG. 36 Company 3 Total Company Revenue 2015-2018 (USD Million) 
FIG. 37 Company 3 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 38 Company 3 Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %) 
FIG. 39 Company 4. Company Net Sales 2015-2018 (USD Million, R & D Expenses %) 
FIG. 40 Company 4. Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 41 Company 4. Company Net Sales, by Region 2015-2018 (USD Million, AGR %) 
FIG. 42 Company 5 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %) 
FIG. 43 Company 5 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %) 
FIG. 44 Primary Research 
FIG. 45 Sources of Secondary Research 
FIG. 46 Forecast Model 

List of Tables

TABLE 1 Global Heart Failure Drugs Market Overview 
TABLE 2 Market Driver Impact Analysis 
TABLE 3 Market Restraints Impact Analysis 
TABLE 4 Global Heart Failure Drugs market Revenue (USD Billion), By Players2018 
TABLE 5 Global Heart Failure Drugs market Revenue Market share (%), By Players- 2018 
TABLE 6 Global Heart Failure Drugs Market Revenue (USD Billion), By Product Type, 2015 - 2025 
TABLE 7 Global Heart Failure Drugs Market Revenue Share (%), By Product Type, 2015 - 2025 
TABLE 8 Global Heart Failure Drugs Market Revenue (USD Billion), By Product Type, 2015 - 2025 
TABLE 9 Global Heart Failure Drugs Market Revenue Share (%), By Product Type, 2015 - 2025 
TABLE 10 Global Heart Failure Drugs Market Revenue (USD Billion), 2015 - 2025 
TABLE 11 Global Heart Failure Drugs Market Revenue Share (%), By , 2015 - 2025 
More …………...
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.